Health Care & Life Sciences » Pharmaceuticals | CMG Pharmaceutical Co. Ltd.

CMG Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
311
158
3,649
1,693
187
Depreciation, Depletion & Amortization
1,116
1,465
1,890
2,101
1,871
Other Funds
57
-
-
52,360
-
Funds from Operations
1,750
2,710
2,043
5,327
6,717
Changes in Working Capital
5,689
1,985
368
2,006
3,984
Net Operating Cash Flow
3,939
725
2,411
3,321
2,732
Capital Expenditures
8,988
13,434
3,635
3,127
2,193
Sale of Fixed Assets & Businesses
117
-
-
3
-
Purchase/Sale of Investments
30,072
177
5,000
53,100
900
Net Investing Cash Flow
21,135
13,611
8,671
56,094
1,251
Issuance/Reduction of Debt, Net
100
5
-
-
-
Net Financing Cash Flow
157
5
-
52,360
171
Net Change in Cash
17,031
12,878
6,261
418
1,650
Free Cash Flow
6,667
8,696
1,737
2,522
1,972
Other Sources
105
-
10
131
101
Change in Capital Stock
-
-
-
-
171
Exchange Rate Effect
9
3
1
4
2
Other Uses
171
-
45
1
59

About CMG Pharmaceutical Co.

View Profile
Address
14 Dosan-daero 66-gil
Seoul SL 06064
Korea, Republic Of
Employees -
Website http://www.cmgpharma.co.kr
Updated 09/14/2018
CMG Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical drugs. Its products include medicine in the form of tablets, capsules, and oral thin film. The company was founded on August 1, 2001 and is headquartered in Seoul, South Korea.